M3258
sel. reversible cov. immunoproteosome inh. oral efficacy (1 mpk) in xeno., Ph. I in MM from SBDD Mol. Cancer Ther., May 27, 2021 Merck KGaA, Darmstadt, DE
Molecules of the Month - May 2021
Molecules of the Month
- GDC-0077
- belvarafenib
- folate-MS432
- TAK-931
- icenticaftor
- MK-8153
- JNJ-61803534
- M3258
- BMS-753426
- LUT014
- GLPG2938
- RRx-001
- compound 7 (GO/LDHA)
- compound 6 (BTK)